Martine A Rothblatt United Therapeutics Corp (UTHR) insider trading activity

Martine A Rothblatt is Chairperson & CEO of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 130 shares of UTHR, which is worth approximately $57,025. The most recent transaction as insider was on Feb 16, 2023, when has been sold 8,000 shares (Common Stock) at a price of $113.08 per share, resulting in proceeds of $904,640. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 130

0% 3M change

0% 12M change

Total Value Held $57,025

MARTINE A ROTHBLATT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 16 2023	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Feb 15 2023	SELL Open market or private sale	$2,021,920 $252.74 p/Share	8,000 Reduced 98.4%	130 Common Stock
Feb 15 2023	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Feb 14 2023	SELL Open market or private sale	$2,045,920 $255.74 p/Share	8,000 Reduced 98.4%	130 Common Stock
Feb 14 2023	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Feb 13 2023	SELL Open market or private sale	$2,040,320 $255.04 p/Share	8,000 Reduced 98.4%	130 Common Stock
Feb 13 2023	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Feb 10 2023	SELL Open market or private sale	$2,036,640 $254.58 p/Share	8,000 Reduced 98.4%	130 Common Stock
Feb 10 2023	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Feb 09 2023	SELL Open market or private sale	$2,032,800 $254.1 p/Share	8,000 Reduced 98.4%	130 Common Stock
Feb 09 2023	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Feb 08 2023	SELL Open market or private sale	$2,030,480 $253.81 p/Share	8,000 Reduced 98.4%	130 Common Stock
Feb 08 2023	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Feb 07 2023	SELL Open market or private sale	$2,029,440 $253.68 p/Share	8,000 Reduced 98.4%	130 Common Stock
Feb 07 2023	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Feb 06 2023	SELL Open market or private sale	$2,055,920 $256.99 p/Share	8,000 Reduced 98.4%	130 Common Stock
Feb 06 2023	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Feb 03 2023	SELL Open market or private sale	$2,062,800 $257.85 p/Share	8,000 Reduced 98.4%	130 Common Stock
Feb 03 2023	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Feb 02 2023	SELL Open market or private sale	$2,052,639 $256.58 p/Share	8,000 Reduced 98.4%	130 Common Stock
Feb 02 2023	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Feb 01 2023	SELL Open market or private sale	$2,085,440 $260.68 p/Share	8,000 Reduced 98.4%	130 Common Stock
Feb 01 2023	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Jan 31 2023	SELL Open market or private sale	$2,093,520 $261.69 p/Share	8,000 Reduced 98.4%	130 Common Stock
Jan 31 2023	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock

MAR

Martine A Rothblatt

Chairperson & CEO

Silver Spring, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Value

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR

Account